Carroll Financial Associates, Inc. - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 75 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 6.89 and the average weighting 0.0%.

Quarter-by-quarter ownership
Carroll Financial Associates, Inc. ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2018$6,0000.0%5,1500.0%0.00%0.0%
Q2 2018$6,000
-14.3%
5,1500.0%0.00%0.0%
Q1 2018$7,000
-58.8%
5,1500.0%0.00%
-50.0%
Q3 2017$17,000
-5.6%
5,1500.0%0.00%0.0%
Q2 2017$18,0005,1500.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,699,848$12,579,0002.08%
Northeast Financial Consultants Inc 732,265$2,490,0000.91%
Family Management Corp 57,424$195,0000.13%
AJ WEALTH STRATEGIES, LLC 29,624$101,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 148,054$503,0000.01%
CSS LLC/IL 26,115$89,0000.00%
THRIVENT FINANCIAL FOR LUTHERANS 298,248$1,014,0000.00%
CSS LLC/IL 16,300$55,0000.00%
Carroll Financial Associates, Inc. 5,150$17,0000.00%
Virtu Financial LLC 14,700$50,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders